结直肠癌肝转移腹腔镜切除术后的复发模式
该研究回顾2000至2016年273例因结直肠癌肝转移行腹腔镜肝切除术的患者,分析复发模式及治疗。中位随访41个月,72%出现复发,中位复发时间16个月;早期复发(<6个月)占22.8%,单部位复发占66%。3年、5年、10年总生存率分别为82%、71%、43%。结论认为腹腔镜肝切除未显示独特复发模式,应尽可能考虑。
要点
- 腹腔镜肝切除治疗结直肠癌肝转移后复发率高,72%患者出现复发。
- 复发以单部位为主(66%),其中肝内复发占44%。
- 淋巴结阳性原发灶、肝切除前肝外疾病和R1切除是复发独立危险因素。
核心结论
- 腹腔镜肝切除治疗结直肠癌肝转移未显示独特的复发模式,且无复发生存和总生存令人满意,应尽可能考虑采用。
研究设计与样本
- 回顾性分析2000至2016年所有因结直肠癌肝转移行腹腔镜肝切除术的患者,共273例,其中157例(57.5%)仅有一个肝转移灶。
- 比较复发与未复发患者,分析无复发生存、总生存及复发和生存的预后因素。
主要发现
- 中位随访41个月(范围12-187个月),27%的患者存在肝外疾病(其中65%为肺部)。
- 中位16个月(范围3-151个月)时,197例(72%)患者出现复发。
- 复发为早期(<6个月)者占22.8%,单部位复发占66%,肝内、肝外及两者兼有分别占44%、30%和26%。
- 复发治疗中,45%接受手术,47%仅接受化疗。
- 3年、5年和10年总生存率分别为82%、71%和43%。
临床怎么用
- 对于结直肠癌肝转移,腹腔镜肝切除可作为可行选择,但需注意复发风险,尤其存在淋巴结阳性原发灶、肝外疾病或R1切除时。
- 术后应密切随访,复发后根据情况选择手术或化疗,复发模式以单部位和肝内常见。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The major issue after liver resection for colorectal liver metastases (CRLM) is the high incidence of recurrence. Unlike open liver resection (OLR), recurrence following laparoscopic liver resection (LLR) is not well documented. The aim of this study was to analyze recurrence patterns and treatment following LLR for CRLM. STUDY DESIGN: All patients who underwent LLR for CRLM from 2000 to 2016 were reviewed. Patients who presented with recurrence were compared to those who did not. Recurrence-free survival (RFS), overall survival (OS), and risk of recurrence and survival prognostic factors were analyzed. RESULTS: Overall, 273 patients were included, of which 157 (57.5%) were treated for one liver metastasis (LM). Median follow-up was 41 (12-187) months and associated extrahepatic disease was present in 27% of patients (mainly pulmonary, 65%). After a median of 16 (3-151) months, 197 (72%) patients presented with recurrence. Recurrences were early (< 6 months) in 22.8% of cases, occured in a single site in 66% and were intrahepatic, extrahepatic, or both in 44, 30, and 26%, respectively. Recurrences were treated with surgery or chemotherapy only in 45 and 47%, respectively. 3-, 5-, and 10-year OS was 82, 71, and 43%, respectively. Independent risk factors for recurrence were node-positive primary tumor, extrahepatic disease before hepatectomy, and R1 resection. CONCLUSION: LLR for CRLM does not seem to be associated with distinctive recurrence patterns. LLR for CRLM yielded satisfying RFS and OS and should therefore be considered whenever possible.
引用
- Tabchouri N, Gayet B, Okumura S, et al. Recurrence patterns after laparoscopic resection of colorectal liver metastases. Surg Endosc. 2018. PMID: 29761279. doi:10.1007/s00464-018-6229-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。